Concepedia

Author

Kenta Masui

Tokyo Women's Medical UniversityORCID

Also Known As

K Masui, K. Masui, Kenta MASUI, Kenta Masui, kenta Masui

139

Publications

4.7K

Citations

30

H-Index

69

Concepts

All Affiliations

Tokyo Women's Medical UniversityUniversity of California San DiegoLudwig Cancer ResearchUniversity of California, Los AngelesTokyo Metropolitan Neurological Hospital
KM

About

Kenta Masui is an author at Tokyo Women's Medical University specializing in medicine, tumor biology, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.2K

2

Management

2

2

24

3

Engineering

1

1

13

4

Health Sciences

1

1

37

5

Natural Sciences

1

1

17

Kenta Masui

×

32

Publications

3.2K

Citations

21

H-Index

YearCitations

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

David A. Nathanson, Beatrice Gini, Jack Mottahedeh,

Science

2013

665

Metabolic state of glioma stem cells and nontumorigenic cells

Erina Vlashi, Chann Lagadec, Laurent Vergnes,

Proceedings of the National Academy of Sciences

2011

528

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

Kenta Masui, Kazuhiro Tanaka, David Akhavan,

Cell Metabolism

2013

390

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment

Kazuhiro Tanaka, Takashi Sasayama, Yasuhiro Irino,

Journal of Clinical Investigation

2015

227

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT

Yuchao Gu, Claudio P. Albuquerque, Daniel Braas,

Molecular Cell

2017

204

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma

Wei Wei, Young Shik Shin, Min Xue,

Cancer Cell

2016

164

EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer

Ivan Babić, Erik S. Anderson, Kazuhiro Tanaka,

Cell Metabolism

2013

158

mTORC2 in the center of cancer metabolic reprogramming

Kenta Masui, Webster K. Cavenee, Paul S. Mischel

Trends in Endocrinology and Metabolism

2014

123

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance

Kenta Masui, Kazuhiro Tanaka, Shiro Ikegami,

Proceedings of the National Academy of Sciences

2015

118

Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma.

Kenji Mishima, Emiko Yamada, Kenta Masui,

PubMed

1998

65

Page 1